LXEO
Lexeo Therapeutics, Inc. Common Stock
stockNASDAQ
At CloseOct 2, 2026 3:59:58 PM EDT
3.54USD-2.210%(-0.08)2,592,096
Loading…
Loading…
290.18M
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Previous Close
$3.62
Beta
1.77
52-Week High
$10.99 2025-12-23
52-Week Low
$2.98 2026-09-29
SMA 50
$4.42
SMA 200
$5.88
Avg. Vol 10D
2.52M
Avg. Vol 30D
1.34M
Avg. Vol 90D
1.08M
Relative Vol
1.93
82.09M
47.42M
57.77%
20,627,916
43.50%
33.44
61%/39%
51.81%
36.51%
0.4100%
1,500,000
29
3,806
20,000
Nov 4, 2026 (30d)
Oct 5, 2026
Stifel reiterates Buy rating on Lexeo Therapeutics stock at $17 · 
Investing.com
Oct 1, 2026
Sep 30, 2026
Sep 29, 2026
Lexeo Therapeutics completes acquisition of Mantle Therapeutics · Investing.com
Sep 23, 2026
LXEO Performance
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 3.14 | 2026-09-28 | +12.58% | -6.165 |
| 1M | 4.89 | 2026-09-04 | -27.71% | 1.414 |
| 3M | 4.60 | 2026-07-06 | -23.15% | 1.177 |
| 6M | 5.77 | 2026-04-06 | -38.73% | 1.767 |
| 1Y | 6.47 | 2025-10-06 | -45.36% | 1.769 |
| 2Y | 8.66 | 2024-10-04 | -59.18% | — |
LXEO Stock Summary
Lexeo Therapeutics, Inc. Common Stock (NASDAQ:LXEO) stock price today is $3.54, and today's volume is 2,592,096. LXEO is down 2.348% today. The 30 day average volume is 1.34M. LXEO market cap is $290.18M with 82.09M shares outstanding.